Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock

United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the stock in a transaction that occurred on Wednesday, April 8th. The stock was sold at an average price of $580.45, for a total value of $5,514,275.00. Following the completion of the transaction, the chief executive officer owned 40,513 shares